Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela King

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Toxicologic Pathology|November 18, 2017
NTP/NIEHS Global Contributions to Toxicologic PathologyRobert Sills, Amy Brix, Mark Cesta, et al.
Journal of Medicinal Chemistry|September 20, 2011
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonistsMario van der Stelt, Jos Cals, Silvia Broeders-Josten, et al.
BMJ Open|May 18, 2022
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocolAshwin D Dhanda, Hannah Allende, Victoria Allgar, et al.
BMJ Open Gastroenterology|January 29, 2024
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial resultsAshwin Dhanda, Jackie Andrade, Hannah Allende, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspectiveMeiLan K Han, Carlos H Martinez, David H Au, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Toxicologic Pathology|November 18, 2017
NTP/NIEHS Global Contributions to Toxicologic PathologyRobert Sills, Amy Brix, Mark Cesta, et al.
Journal of Medicinal Chemistry|September 20, 2011
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonistsMario van der Stelt, Jos Cals, Silvia Broeders-Josten, et al.
BMJ Open|May 18, 2022
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocolAshwin D Dhanda, Hannah Allende, Victoria Allgar, et al.
BMJ Open Gastroenterology|January 29, 2024
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial resultsAshwin Dhanda, Jackie Andrade, Hannah Allende, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspectiveMeiLan K Han, Carlos H Martinez, David H Au, et al.
Pageof 4